Grant: Collaborative Research and Development Grants
École Polytechnique de Montréal
$73,224.00
Optimization of the Mechano-Acoustic Frequencer(TM) to clear airways
FY 2019-20
Summary
Canada ranked 8th among 16 peer countries for deaths related to respiratory diseases, with an average of 63.1 deaths per 100 000 between 2009 and 2011. Dymedso manufactures the Frequencer that promotes bronchial drainage by low frequency sound waves. The therapy is much gentler than the traditional ""clapping"" method (frequency in the 20-67 Hz range). Dymedso's customers reported that a frequency between 37 to 42 Hz eases mucous clearance compared to lower or higher frequencies. In a recent study, the team of Prof. Boffito identified that at a frequency of 40 Hz, 50 % amplitude and in the presence of a NaCl solution of 0.5 gL-1, mucous rehydrates and its viscosity decreases by 30%. Dymedso now wishes to expand the scope of the research and take into consideration more aspects involved in mucous clearance under the action of the Frequencer. This project involves Prof. Boffito (EPM), Prof. Poncet and Prof. Micheau (UdeS) and consists of both experimental work and numerical modelling. We will test the Frequencer at different frequencies, amplitudes and NaCl concentrations. Besides measuring the thermophysical and rheological properties, slip/peel tests after the vibrational test will identify the mechanism of mucous clearance. This part includes designing a predictive rheological model that takes into account all the variables above (EPM). We will model geometrical details of the human torso, determine the acoustic waves penetration depth and build a chest vibration map to visualize vibration distribution and mucous displacement in the lungs at different Frequencer's operating conditions (UdeS). The main deliverable is an improved design of the Frequencer, including head height, operating power and frequency, optimal concentration of saline spray (to minimize acute effects and make it tolerable). The success of this project will have a huge impact on the health and life quality of Canadian people having a respiratory disease linked to bronchial mucus. This project will train 2 PhD students, 2 postdocs and 9 undergraduate students. Dymedso will benefit from the commercialization of the a new design of the Frequencer, as well as from the deep insights of its way of operation.
Program
Collaborative Research and Development Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
536746-2019
Name nom
Boffito, DariaCamilla
Department département
Génie chimique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
73224
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1805
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Transport processes
Research subject fr
Procédés de transfert
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Optimization of the Mechano-Acoustic Frequencer(TM) to clear airways
Keyword
NSERC
Application summary
Canada ranked 8th among 16 peer countries for deaths related to respiratory diseases, with an average of 63.1 deaths per 100 000 between 2009 and 2011. Dymedso manufactures the Frequencer that promotes bronchial drainage by low frequency sound waves. The therapy is much gentler than the traditional ""clapping"" method (frequency in the 20-67 Hz range). Dymedso's customers reported that a frequency between 37 to 42 Hz eases mucous clearance compared to lower or higher frequencies. In a recent study, the team of Prof. Boffito identified that at a frequency of 40 Hz, 50 % amplitude and in the presence of a NaCl solution of 0.5 gL-1, mucous rehydrates and its viscosity decreases by 30%. Dymedso now wishes to expand the scope of the research and take into consideration more aspects involved in mucous clearance under the action of the Frequencer. This project involves Prof. Boffito (EPM), Prof. Poncet and Prof. Micheau (UdeS) and consists of both experimental work and numerical modelling. We will test the Frequencer at different frequencies, amplitudes and NaCl concentrations. Besides measuring the thermophysical and rheological properties, slip/peel tests after the vibrational test will identify the mechanism of mucous clearance. This part includes designing a predictive rheological model that takes into account all the variables above (EPM). We will model geometrical details of the human torso, determine the acoustic waves penetration depth and build a chest vibration map to visualize vibration distribution and mucous displacement in the lungs at different Frequencer's operating conditions (UdeS). The main deliverable is an improved design of the Frequencer, including head height, operating power and frequency, optimal concentration of saline spray (to minimize acute effects and make it tolerable). The success of this project will have a huge impact on the health and life quality of Canadian people having a respiratory disease linked to bronchial mucus. This project will train 2 PhD students, 2 postdocs and 9 undergraduate students. Dymedso will benefit from the commercialization of the a new design of the Frequencer, as well as from the deep insights of its way of operation.